ReidMC, SchoenRT, EvansJ, RosenbergJC, HorwitzRI. The consequences of over diagnosis and over treatment of Lyme disease: An observational study. Ann Intern Med, 1998; 128:354–362.
3.
SteereAC, TaylorE, McHughGL, LogigianEL. The over diagnosis of Lyme disease. JAMA, 1993; 269:1812–1826.
4.
RoseCD, FawcettPT, GibneyKM, DoughtyRA. The over diagnosis of Lyme disease in children residing in an endemic area. Clin Pediatr, 1994; 33:663–668.
5.
WormserGP, ShapiroED. Implications of gender in chronic Lyme disease. J Womens Health, 2009; 18:831–834.
6.
JasonLA, RichmanJA, RademakerAWet al.A community-based study of chronic fatigue syndrome. Arch Intern Med, 1999; 159:2129–2137.
7.
BuchwaldD, PearlmanT, KithP, SchmalingK. Gender differences in patients with chronic fatigue syndrome. J Gen Intern Med, 1994; 9:397–401.
8.
MunceSEP, StewartDE. Gender differences in depression and chronic pain conditions in a national epidemiologic survey. Psychosomatics, 2007; 48:394–399.
9.
PetzkeF, GracelyRH, ParkKM, AmbroseK, ClauwDJ. What do tender points measure? Influence of distress on four measures of tenderness. J Rheumatol, 2003; 30:567–574.
10.
GranJT. The epidemiology of chronic generalized musculoskeletal pain. Best Pract Res Clin Rheum, 2003; 17:547–561.
11.
YunusMB. The role of gender in fibromyalgia syndrome. Curr Rheum Rep, 2001; 3:128–134.
12.
HassettAL, RadvanskiDC, BuyskeSet al.Role of psychiatric co-morbidity in chronic Lyme disease. Arthritis Rheum, 2008; 59:1742–1749.
WormserGP, NowakowskiJ, NadelmanRBet al.Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease. Clin Vaccine Immunol, 2008; 15:1519–1522.
TreadwellTA, HolmanRC, ClarkeMJ, KrebsJW, PaddockCD, ChildsJE. Rocky mountain spotted fever in the United States, 1993–1996. Am J Trop Med Hyg, 2000; 63:21–26.
17.
GardnerSL, HolmanRC, KrebsJW, BerkelmanR, ChildJE. National surveillance for the human ehrlichiosis in the United States, 1997–2001, and proposed methods for evaluation of data quality. Ann NY Acad Sci, 2003; 990:80–89.
18.
Centers for Disease Control and Prevention. Tularemia—United States, 1990–2000. MMWR, 2002; 51:182–184.
19.
ReimannCA, HayesEB, DiGuiseppiCet al.Epidemiology of neuroinvasive arboviral disease in the United States, 1999–2007. Am J Trop Med Hyg, 2008; 79:974–979.
20.
KruppLB, HymanLG, GrimsonRet al.Study and treatment of post-Lyme disease (Stop-LD). A randomized double-masked clinical trial. Neurology, 2003; 60:1923–1930.
21.
KlempnerMS, HuLT, EvansJet al.Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med, 2001; 345:85–92.
DontaST. Macrolide therapy of chronic Lyme disease. Med Sci Monit, 2003; 9:1136–1142.
24.
MarquesA, BrownMR, FleisherTA. Natural killer cell counts are not different between patients with post-Lyme disease syndrome and controls. Clin Vaccine Immunol, 2009June 10 (e-pub ahead of print).
